{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T12:53:22Z","timestamp":1793969602770,"version":"4.8.0"},"reference-count":22,"publisher":"Impact Journals, LLC","issue":"37","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2018,5,15]]},"DOI":"10.18632\/oncotarget.25340","type":"journal-article","created":{"date-parts":[[2018,5,15]],"date-time":"2018-05-15T15:10:34Z","timestamp":1526397034000},"page":"24731-24736","source":"Crossref","is-referenced-by-count":26,"title":["Cirmtuzumab inhibits ibrutinib-resistant, Wnt5a-induced Rac1 activation and proliferation in mantle cell lymphoma"],"prefix":"10.18632","volume":"9","author":[{"given":"Jian","family":"Yu","sequence":"first","affiliation":[{"name":"Moores Cancer Center, University of California, San Diego, La Jolla, CA 92093, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Chen","sequence":"additional","affiliation":[{"name":"Moores Cancer Center, University of California, San Diego, La Jolla, CA 92093, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liguang","family":"Chen","sequence":"additional","affiliation":[{"name":"Moores Cancer Center, University of California, San Diego, La Jolla, CA 92093, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Zhang","sequence":"additional","affiliation":[{"name":"Moores Cancer Center, University of California, San Diego, La Jolla, CA 92093, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura Z.","family":"Rassenti","sequence":"additional","affiliation":[{"name":"Moores Cancer Center, University of California, San Diego, La Jolla, CA 92093, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"II","given":"George F.","family":"Widhopf","sequence":"additional","affiliation":[{"name":"Moores Cancer Center, University of California, San Diego, La Jolla, CA 92093, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Kipps","sequence":"additional","affiliation":[{"name":"Moores Cancer Center, University of California, San Diego, La Jolla, CA 92093, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2018,5,15]]},"reference":[{"key":"1","first-page":"585","article-title":"Wnt5a induces ROR1\/ROR2 heterooligomerization to enhance leukemia chemotaxis and proliferation","volume":"126","author":"Kipps","year":"2016","journal-title":"J Clin Invest"},{"key":"2","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1038\/leu.2016.368","article-title":"Cirmtuzumab inhibits Wnt5a-induced Rac1 activation in chronic lymphocytic leukemia treated with ibrutinib","volume":"31","author":"Kipps","year":"2017","journal-title":"Leukemia"},{"key":"3","doi-asserted-by":"crossref","first-page":"S167","DOI":"10.1016\/j.clml.2015.02.010","article-title":"Pre-clinical Specificity, Safety of UC-961, a First-In-Class Monoclonal Antibody Targeting ROR1","volume":"15","author":"Kipps","year":"2015","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"4","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/hon.948","article-title":"ROR1 expression is not a unique marker of CLL","volume":"29","author":"Matolcsy","year":"2011","journal-title":"Hematol Oncol"},{"key":"5","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1073\/pnas.1308374111","article-title":"ROR1 can interact with TCL1 and enhance leukemogenesis in Emu-TCL1 transgenic mice","volume":"111","author":"Kipps","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/sj.leu.2401664","article-title":"Proliferative response of mantle cell lymphoma cells stimulated by CD40 ligation and IL-4","volume":"14","author":"Schattner","year":"2000","journal-title":"Leukemia"},{"key":"7","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1038\/sj.leu.2401829","article-title":"Mantle cell lymphoma proliferates upon IL-10 in the CD40 system","volume":"14","author":"Kluin-Nelemans","year":"2000","journal-title":"Leukemia"},{"key":"8","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.1182\/blood-2014-02-548610","article-title":"Ibrutinib inhibits BCR, NF-kappaB signaling and reduces tumor proliferation in tissue-resident cells of patients with CLL","volume":"123","author":"Wiestner","year":"2014","journal-title":"Blood"},{"key":"9","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/leu.2013.358","article-title":"BTK inhibition targetsCLL proliferation through its effects on B-cell receptor signaling activity","volume":"28","author":"Wang","year":"2014","journal-title":"Leukemia"},{"key":"10","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.cellsig.2013.01.015","article-title":"Rab35 is required for Wnt5a\/Dvl2-induced Rac1 activation and cell migration in MCF-7 breast cancer cells","volume":"25","author":"Gu","year":"2013","journal-title":"Cell Signal"},{"key":"11","doi-asserted-by":"crossref","first-page":"3610","DOI":"10.1128\/MCB.00177-10","article-title":"Ror2\/Frizzled complex mediates Wnt5a-induced AP-1 activation by regulating Dishevelled polymerization","volume":"30","author":"Minami","year":"2010","journal-title":"Mol Cell Biol"},{"key":"12","doi-asserted-by":"crossref","first-page":"4386","DOI":"10.4049\/jimmunol.1302817","article-title":"Wnt5a-Rac1-NF-kappaB homeostatic circuitry sustains innate immune functions in macrophages","volume":"192","author":"Sen","year":"2014","journal-title":"J Immunol"},{"key":"13","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1074\/jbc.M115.687251","article-title":"Analysis of the Effects of the Bruton\u2019s tyrosine kinase (Btk) Inhibitor Ibrutinib on Monocyte Fcgamma Receptor (FcgammaR) Function","volume":"291","author":"Tridandapani","year":"2016","journal-title":"J Biol Chem"},{"key":"14","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1182\/blood-2013-08-523563","article-title":"Tiam1\/Rac1 signals contribute to the proliferation and chemoresistance, but not motility, of chronic lymphocytic leukemia cells","volume":"123","author":"Hartmann","year":"2014","journal-title":"Blood"},{"key":"15","doi-asserted-by":"crossref","first-page":"6214","DOI":"10.1182\/blood-2010-08-301283","article-title":"The small GTPase Rac1 is a novel binding partner of Bcl-2 and stabilizes its antiapoptotic activity","volume":"117","author":"Pervaiz","year":"2011","journal-title":"Blood"},{"key":"16","doi-asserted-by":"crossref","first-page":"5235","DOI":"10.1182\/blood-2011-04-351817","article-title":"Inhibition of Rac GTPase signaling and downstream prosurvival Bcl-2 proteins as combination targeted therapy in MLL-AF9 leukemia","volume":"118","author":"Mulloy","year":"2011","journal-title":"Blood"},{"key":"17","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.1182\/blood-2009-02-202440","article-title":"Rac1 targeting suppresses p53 deficiency-mediated lymphomagenesis","volume":"115","author":"Zheng","year":"2010","journal-title":"Blood"},{"key":"18","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1126\/science.1088485","article-title":"Hematopoietic cell regulation by Rac1 and Rac2 guanosine triphosphatases","volume":"302","author":"Williams","year":"2003","journal-title":"Science"},{"key":"19","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/hon.2380","article-title":"Predictive factors and outcomes for ibrutinib therapy in relapsed\/refractory mantle cell lymphoma-a \u201creal world\u201d study","volume":"35","author":"Costa","year":"2017","journal-title":"Hematol Oncol"},{"key":"20","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1056\/NEJMoa1306220","article-title":"Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma","volume":"369","author":"Radford","year":"2013","journal-title":"N Engl J Med"},{"key":"21","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJMoa1215637","article-title":"Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia","volume":"369","author":"Heerema","year":"2013","journal-title":"N Engl J Med"},{"key":"22","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1073\/pnas.0712148105","article-title":"Antisera induced by infusions of autologous Ad-CD154-leukemia B cells identify ROR1 as an oncofetal antigen and receptor for Wnt5a","volume":"105","author":"Kipps","year":"2008","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.25340","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T18:14:46Z","timestamp":1594836886000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.25340"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,15]]},"references-count":22,"journal-issue":{"issue":"37","published-print":{"date-parts":[[2018,5,15]]}},"alternative-id":["25340","29872501"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.25340","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,15]]}}}